BACKGROUND: The prevalence of asthma is strikingly different in some Westernized countries: approximately 20% in New Zealand and approximately 8% in northern Sweden. OBJECTIVE: We investigated differences in total IgE and in the prevalence of wheezing related to the observation that high exposure to dust mite allergens induces high titers of IgE antibodies. METHODS: Two age-matched, population-based cohorts-1155 children in New Zealand (224 sera) and 3431 children (797 sera) in the Norrbotten area of Sweden-were studied. Sera were assayed for total IgE and specific IgE antibodies to relevant allergens. RESULTS: The mean total IgE among wheezing children was higher in New Zealand than Sweden (218 IU/mL vs 65.2 IU/mL; P < .001). In addition, the prevalence of high titer specific IgE antibody (> or =50 IU/mL) was greater among the wheezing children in New Zealand compared with Sweden (35.7% vs 13.0%; P < .001). Specific IgE antibody to mite in New Zealand was significantly related to high total IgE (> or =200 IU/mL; r = 0.47; P < .001), whereas the IgE antibody response to cat allergens did not make a significant contribution to high total IgE in either country. CONCLUSION: The quantity of IgE antibody produced to dust mite provides a possible explanation for the higher total IgE levels found in children in New Zealand and may help to explain the differences in prevalence and severity of asthma between these 2 countries. CLINICAL IMPLICATIONS: Specific IgE antibody responses to dust mite and cat allergens may contribute differently to total serum IgE and to the prevalence of allergic disease.
BACKGROUND: The prevalence of asthma is strikingly different in some Westernized countries: approximately 20% in New Zealand and approximately 8% in northern Sweden. OBJECTIVE: We investigated differences in total IgE and in the prevalence of wheezing related to the observation that high exposure to dust mite allergens induces high titers of IgE antibodies. METHODS: Two age-matched, population-based cohorts-1155 children in New Zealand (224 sera) and 3431 children (797 sera) in the Norrbotten area of Sweden-were studied. Sera were assayed for total IgE and specific IgE antibodies to relevant allergens. RESULTS: The mean total IgE among wheezingchildren was higher in New Zealand than Sweden (218 IU/mL vs 65.2 IU/mL; P < .001). In addition, the prevalence of high titer specific IgE antibody (> or =50 IU/mL) was greater among the wheezingchildren in New Zealand compared with Sweden (35.7% vs 13.0%; P < .001). Specific IgE antibody to mite in New Zealand was significantly related to high total IgE (> or =200 IU/mL; r = 0.47; P < .001), whereas the IgE antibody response to cat allergens did not make a significant contribution to high total IgE in either country. CONCLUSION: The quantity of IgE antibody produced to dust mite provides a possible explanation for the higher total IgE levels found in children in New Zealand and may help to explain the differences in prevalence and severity of asthma between these 2 countries. CLINICAL IMPLICATIONS: Specific IgE antibody responses to dust mite and cat allergens may contribute differently to total serum IgE and to the prevalence of allergic disease.
Authors: Scott P Commins; Libby A Kelly; Eva Rönmark; Hayley R James; Shawna L Pochan; Edward J Peters; Bo Lundbäck; Lucy W Nganga; Philip J Cooper; Janelle M Hoskins; Saju S Eapen; Luis A Matos; Dane C McBride; Peter W Heymann; Judith A Woodfolk; Matthew S Perzanowski; Thomas A E Platts-Mills Journal: Am J Respir Crit Care Med Date: 2012-01-26 Impact factor: 21.405
Authors: Thomas A E Platts-Mills; Alexander J Schuyler; Elizabeth A Erwin; Scott P Commins; Judith A Woodfolk Journal: J Allergy Clin Immunol Date: 2016-04-27 Impact factor: 10.793
Authors: J A Wisniewski; R Agrawal; S Minnicozzi; W Xin; J Patrie; P W Heymann; L Workman; T A Platts-Mills; T W Song; M Moloney; J A Woodfolk Journal: Clin Exp Allergy Date: 2013-10 Impact factor: 5.018
Authors: Elizabeth A Erwin; Jake Hosen; Susan M Pollart; Michael J Reid; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2009-01-18 Impact factor: 10.793
Authors: Kathleen M Donohue; Umaima Al-alem; Matthew S Perzanowski; Ginger L Chew; Alina Johnson; Adnan Divjan; Elizabeth A Kelvin; Lori A Hoepner; Frederica P Perera; Rachel L Miller Journal: J Allergy Clin Immunol Date: 2008-11 Impact factor: 10.793